Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Common Equity (2016 - 2025)

Bruker (BRKR) has disclosed Common Equity for 16 consecutive years, with $2.5 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity rose 37.91% year-over-year to $2.5 billion, compared with a TTM value of $2.5 billion through Dec 2025, up 37.91%, and an annual FY2025 reading of $2.5 billion, up 37.91% over the prior year.
  • Common Equity was $2.5 billion for Q4 2025 at Bruker, up from $2.4 billion in the prior quarter.
  • Across five years, Common Equity topped out at $2.5 billion in Q4 2025 and bottomed at $948.0 million in Q3 2022.
  • Average Common Equity over 5 years is $1.4 billion, with a median of $1.2 billion recorded in 2023.
  • The sharpest move saw Common Equity decreased 13.0% in 2022, then soared 48.73% in 2024.
  • Year by year, Common Equity stood at $1.1 billion in 2021, then increased by 3.79% to $1.1 billion in 2022, then rose by 23.89% to $1.4 billion in 2023, then grew by 27.72% to $1.8 billion in 2024, then soared by 37.91% to $2.5 billion in 2025.
  • Business Quant data shows Common Equity for BRKR at $2.5 billion in Q4 2025, $2.4 billion in Q3 2025, and $1.8 billion in Q2 2025.